Compare BGS & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | FHTX |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.1M | 323.4M |
| IPO Year | 2004 | 2020 |
| Metric | BGS | FHTX |
|---|---|---|
| Price | $3.56 | $4.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $4.90 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 2.0M | 333.7K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 14.34% | N/A |
| EPS Growth | ★ 83.02 | 25.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,828,687,000.00 | $30,909,000.00 |
| Revenue This Year | N/A | $8.89 |
| Revenue Next Year | $0.52 | $20.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $3.50 | $3.27 |
| 52 Week High | $6.38 | $6.95 |
| Indicator | BGS | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 40.56 |
| Support Level | N/A | $4.37 |
| Resistance Level | $4.18 | $4.64 |
| Average True Range (ATR) | 0.12 | 0.33 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 15.00 | 9.47 |
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.